Aceso Life Science Group (HKSE:00474) Cyclically Adjusted PS Ratio: (As of Sep. 16, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:00474 Aceso Life Science Group Ltd HKSE:00474
19 GF Score
Price HK$0.15
GF Value HK$0.03
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Aceso Life Science Group Cyclically Adjusted PS Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Aceso Life Science Group  (HKSE:00474) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Aceso Life Science Group Cyclically Adjusted PS Ratio Related Terms


Aceso Life Science Group Cyclically Adjusted PS Ratio Historical Data

* Premium members only.

The historical data trend for Aceso Life Science Group's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aceso Life Science Group Cyclically Adjusted PS Ratio Chart

Aceso Life Science Group Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.63 1.84 1.62 5.10 0.00

Aceso Life Science Group Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.21 1.31 1.24 6.27 0.00

HKSE:00474 vs URI, SUNB, AER: Cyclically Adjusted PS Ratio Comparison

For the Rental & Leasing Services subindustry, Aceso Life Science Group's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aceso Life Science Group Cyclically Adjusted PS Ratio vs Business Services Industry

For the Business Services industry and Industrials sector, Aceso Life Science Group's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Aceso Life Science Group's Cyclically Adjusted PS Ratio falls into.


HKSE:00474
19GF Score
Aceso Life Science Group Ltd HKSE:00474
Cyclically Adjusted PS Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Aceso Life Science Group Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Aceso Life Science Group's Cyclically Adjusted Revenue per Share for the fiscal year that ended in Mar26 is calculated as:

For example, Aceso Life Science Group's adjusted Revenue per Share data for the fiscal year that ended in Mar26 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar26 (Change)*Current CPI (Mar26)
=0.009/121.4731*121.4731
=0.009

Current CPI (Mar26) = 121.4731.

Aceso Life Science Group Annual Data

Revenue per Share CPI Adj_RevenuePerShare
201703 -0.588 103.335 -0.691
201803 0.040 105.973 0.046
201903 -0.013 108.172 -0.015
202003 0.067 110.920 0.073
202103 0.056 111.579 0.061
202203 0.047 113.558 0.050
202303 0.050 115.427 0.053
202403 0.037 117.735 0.038
202503 0.007 119.384 0.007
202603 0.009 121.473 0.009

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Aceso Life Science Group (HKSE:00474) Overvalued in 2026?

Based on GuruFocus' analysis, Aceso Life Science Group stock appears to be overvalued. The current stock price of HK$0.15 is trading 386.7% above its estimated GF Value™ of HK$0.03. GuruFocus considers Aceso Life Science Group to be Significantly Overvalued.

Key valuation signals for HKSE:00474:

  • Cyclically Adjusted PS Ratio:
  • GF Value™: HK$0.03 vs. price of HK$0.15 (386.7% above fair value)
  • GF Score™: 19/100 with 6 warning signs

No single metric tells the full story. See the HKSE:00474 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Aceso Life Science Group Business Description

Address 6 - 8 Harbour Road, Rooms 2501 - 2509, 25th Floor, Shui On Centre, Wanchai, Hong Kong, HKG
Aceso Life Science Group Ltd is an investment holding company. The group's operating segments include Money lending, Rental and sale of construction machinery and spare parts business, Provision of repair and maintenance and transportation service business, Provision of asset management, securities brokerage, commodities, futures, and other financial service business, Property leasing business, and Property development business. It derives key revenue from the rental and sale of construction machinery and spare parts. Geographically, the group has a business presence in Hong Kong, the UK, the PRC, Macau, and Cambodia.
19GF Score

Get the complete analysis for HKSE:00474

Cyclically Adjusted PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$0.15
Price
HK$0.03
GF Value